Investment analysts at Wedbush lifted their FY2029 EPS estimates for shares of Apellis Pharmaceuticals in a note issued to ...

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Equities researchers at Wedbush issued their Q1 2026 earnings per share (EPS) estimates for Nuvation Bio in a report issued on Thursday, March 6th. Wedbush analyst D. Nierengarten forecasts that the ...

Nvidia (NASDAQ:NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes it ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange Commission to enter the ETF space. According to the filing, the proposed ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI ...

Tesla (TSLA) stock has landed on Wedbush’s “best ideas list” as analyst Daniel Ives reaffirmed his bullish stance on the ...